January 23, 2017 10:52 AM EST

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics

John Carroll

Editor & Founder

Under the most heated political attack the drug industry has ever faced on Capitol Hill, the lobbying powerhouse PhRMA is rolling out its most ambitious …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics

John Carroll

Editor & Founder

Sign up to read this article for free.

Uro-Oncology Business Manager

ImmunityBio, Inc.

Remote

Drugmakers see a substantial, but manageable, hit to business from tariffs. But the worst may lie ahead

Bristol Myers CEO signals dealmaking will be a top priority in 2025

Roche CEO warns that tariffs could impact dealmaking

Roche takes steps to protect itself from tariffs, while Sanofi hangs back

Sanofi's Altuviiio closing in on blockbuster status, Dupixent sales surge

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

Fac­ing a deep­en­ing po­lit­i­cal cri­sis, PhRMA launch­es a ma­jor coun­ter­at­tack against its le­gion of crit­ics

Editor & Founder

Sign up to read this article for free.

ImmunityBio, Inc.

Remote

Facing a deepening political crisis, PhRMA launches a major counterattack against its legion of critics